Trial Search Results
Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia
This study tested whether Neonatal Intensive Care Unit (NICU) teams trained in benchmarking -- comparing care practices between different NICUs to see which practices prevent bronchopulmonary dysplasia (BPD) -- and quality improvement would change practices and improve rates of survival without BPD in inborn neonates with birth weights of <1250 grams. Benchmarking is a method involving detailed comparisons of processes between similar organizations. For this study, three NRN centers with the lowest rates of BPD have been identified as Benchmark centers. During a 6-month pre-intervention period, details of care practices and management style at these centers were carefully assessed. Based on practices at these Benchmarking sites, we developed a quality improvement program. For this study, 14 other NRN sites were randomized to either implement the benchmarking intervention (intervention sites) or continue with their usual care practices (control sites). After the 1-year intervention period, we compared changes in the rate of survival without BPD at 36 weeks corrected age between the intervention and control sites.
Stanford is currently not accepting patients for this trial.
NICHD Neonatal Research Network
Collaborator: National Center for Research Resources (NCRR)
- Other: Benchmarking Management Practices
- Other: Standard Management Practices
- Infants 501-1,249g birthweight
- Registered in a participating site
- Diagnosed with a syndrome as defined by the Neonatal Research Network's Generic
Ages Eligible for Study
N/A - 36 Weeks
Genders Eligible for Study